Up 38% in a year, is this UK share still attractively priced?

Christopher Ruane explains some pros and cons he sees in adding a FTSE 100 UK share with strong recent price gains to his portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Bus waiting in front of the London Stock Exchange on a sunny day.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Information services provider RELX (LSE: REL) has been on a great run in the stock market lately. In the past year alone, the UK share has moved up 38%. Over five years, the increase has been 84%.

The business has been doing well – but is the current share price an attractive one at which to add the FTSE 100 share to my portfolio?

Attractive mixture of businesses

I like the investment case for RELX.

Its business spans a number of areas that have customers who want a product and have few or no alternatives. From academic journals to legal information databases, RELX has built a product portfolio that benefits from strong pricing power. That is good for profitability.

Last year, for example, the company turned over £9.1bn and made post-tax profits of £1.8bn. That comes out to a net profit margin of 19.5%.

The business has been able to fund often strong dividend growth thanks to this lucrative model. Last year, for example, the payout per share grew 8% on the back of a 10% increase over the prior year.

Valuation looks hard to justify

Despite that, the current yield is a meagre 1.6%.

The reason for that is simple. A yield reflects how much each share earns annually in dividends – and the current share price. So a rising share price typically pushes down the yield.

That can be offset by a growth in the payout per share. RELX’s dividend per share has been growing handily. But the share price has been growing even faster, as the gain of almost two-fifths in the past year demonstrates.

Such a sharp share price jump has implications for valuation, too.

The price-to-earnings (P/E) ratio for RELX shares now stands at 38. For a mature company in a mostly sedate though profitable business area, that strikes me as too high.

Could this good business be a good investment for me?

It is not just that the company faces risks, such as ongoing challenges in building its exhibition business profitability to pre-pandemic levels and the risk that currency moves could pose to earnings from its heavily international business.

Even setting aside those risks momentarily (though they are real), I think the valuation is difficult to justify.

The P/E ratio is higher than US growth shares like Meta and almost the same as Microsoft. I think the investment case for RELX is strong. But I do not think it has the sorts of long-term business growth prospects of those US tech giants, whose valuations anyway also look costly to me.

If I had bought into RELX at a much lower price I would be happy to hold it for the long term, earning a higher yield than if I bought today.

At the current price, though, this blue-chip UK share looks too expensive to whet my appetite for buying.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. C Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Meta Platforms, Microsoft, and RELX. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Value Shares

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

What can Warren Buffett teach an investor with £1,000?

Although Warren Buffett’s a billionaire, his investing lessons can be applied to far more modest portfolios. Our writer explains some…

Read more »

Investing Articles

Analysts are saying the AstraZeneca share price looks cheap despite China turmoil

The AstraZeneca share price could be considerably undervalued according to analysts. Dr James Fox takes a closer look at the…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

1 FTSE 100 stock I expect to outperform in 2025

Can the integration of its big acquisition from 2022 finally lead Rentokil Initial to outperform the FTSE 100 next year?…

Read more »

Investing Articles

Here’s my FTSE 250 share index prediction for 2025

The FTSE 250 index of shares has endured disappointing growth in recent times. Could 2025 be the year that it…

Read more »

Investing Articles

Here’s why I think the Barclays share price could top the FTSE 100 banks in 2025

The Barclays share price has seen a strong resurgence in 2024 after years out in the cold. Can 2025 carry…

Read more »

New year resolutions 2025 on desk. 2025 resolutions list with notebook, coffee cup on table.
Investing Articles

4 FTSE 100 takeover targets for 2025

Takeover activity has picked up and undervalued FTSE 100 stocks are clearly being targeted. Dr James Fox takes a closer…

Read more »

Investing Articles

The simple reasons the Lloyds share price will recover in 2025 and beyond

There are simple reasons why the Lloyds share price should recover in 2025 and beyond. Dr James Fox highlights how…

Read more »

Investing Articles

FTSE shares: a brilliant opportunity for investors to get rich?

With valuations in the US looking full, Paul Summers thinks there's a good chance that FTSE stocks might become more…

Read more »